Abstract 13,-3H, 24-"qLithocholic, chenodeoxycholic, and cholic acids were administered in tracer bolus doses either prograde or retrograde in the isolated perfused rat liver. Little 3H loss from cholic acid was observed, whereas with the other bile acids, 20-40% of the administered 3H was lost in a single pass from perfusate to bile. Most of the 3H loss occurred rapidly (5 min) and was recovered as IHlwater in perfusate. Excretion of bile acids was delayed with retrograde administration, and 3H loss was more extensive. In both prograde and retrograde studies, indomethacin markedly inhibited the excretion of the bolus of bile acid into bile. Indomethacin inhibited the extraction of glycocholate (50 g&M) during steady state perfusion without affecting transport maximum for excretion. At lower glycocholate concentration (5 juM), indomethacin inhibited both extraction and excretion. A greater effect was seen on excretion in the latter case, which suggests that displacement of bile acid from the cytosolic protein lead to redistribution in the hepatocyte as well as reflux into the sinusoid. These data suggest that binding of bile acids to cytosolic 3a-hydroxysteroid dehydrogenases occurs extensively during hepatic transit and is important in mediating the translocation of bile acids from the sinusoidal to canalicular pole of the cell.
Introduction
The process by which bile acids are translocated intracellularly from sinusoidal to canalicular pole of hepatocytes is poorly understood. Bile acid binding by cytosolic proteins has been proposed as having an important role in intracellular transport of bile acids. We have characterized previously the binding properties of the major cytosolic bile acid binding proteins in rat liver (1) (2) (3) (4) . These proteins include GSH S-transferases (1-3), Y' bile acid binders (1) , and Z protein (4) . Recently, we have reported that Y' bile acid binders are 3a-hydroxysteroid dehydrogenases (3a-HSD),I which can catalyze oxidation or reduction of the 3 position (C3) of bile acids depending on cofactor concentrations and pH (5) . Under physiological redox and pH conditions, this cytosolic enzyme in pure form or in hepatocytes catalyzes the net conversion of 3-oxo bile acid to 3a-hydroxy bile acid and not vice versa (5) . This enzyme also exclusively catalyzes the back-and-forth equilibrium cycling of bile acids (3a-OH 3-oxo) without net conversion to 3-oxo bile acids in hepatocytes. Thus, by using [3,8-3H , 24-'4C]bile acids, loss of 3H can be used to specifically probe the interaction of bile acids with cytosolic 3a-HSD in hepatocytes. Furthermore, indomethacin, a competitive inhibitor of 3a-HSD, can be used to assess the effects of inhibition of the interaction of bile acids with 3a-HSD. In the accompanying manuscript, we found that indomethacin significantly shifted the equilibrium distribution of bile acids from cells to media without affecting initial uptake rates. In those experiments, isolated hepatocytes have lost their polarity and the bile acids have the opportunity to cycle in and out of the cells. The significance of bile acid binding to 3a-HSD as reflected in 3H loss, in the vectorial transport and extent of equilibrium cycling during a single transit from sinusoid to bile could not be assessed in this model. Therefore, in the present paper we have extended this work to a more physiologic model, the isolated perfused rat liver. With this model, we have assessed the extent of 3H loss during one transit from perfusate to bile in the periportal or pericentral zones and have examined the effect of indomethacin on 3H loss, rate of excretion, and extraction of bile acid.
Methods
Preparation of [3#_-3H, 24 3H/'4C ratios of the samples were calculated after the correction of the crossover of "'C counts into the 3H channel. During all perfusion studies, 02 uptake (2 Mmol/min per g liver) and the hydrostatic perfusion pressure (-5 cm H20) remained constant. Bile flow immediately decreased after bile duct cannulation (-50-25 Ml/h per g body wt) presumably because of the decrease of biliary bile acid excretion. After injection of bile acids, bile flow continued to decline gradually; -20% decrease of bile flow was observed during 60 min. Infusion ofindomethacin increased bile flow -40% in prograde perfusion only. There was no detectable cell damage during all perfusions, as monitored by glutathione S-transferase activity in perfusates, which were checked every 10 min by the method of Habig (9) .
Exogenous bile acid excretion. Bile acid concentrations in bile samples were determined by the method of Paumgartner (10) using bacterial 3a-HSD. Initial bile acid outputs after cannulation were 95±21 nmol/min per g liver. The output rapidly decreased and remained between 1.5 and 2.5 nmol/min per g during the experimental intervals before and up to 60 min after tracer administration in the presence or absence of indomethacin.
Thin-layer chromatography (TLC) analysis of radioactive bile acids. Aliquots of pooled bile samples collected in the 60-min interval after the injection ofbile acid were analyzed by TLC. Bile samples were subjected to deconjugation by cholylglycine hydrolase at 370C for 16 h, as previously reported (6) . After incubation, the mixture was adjusted to pH 8 with sodium phosphate buffer and applied onto prewashed Sep Pak C18 cartridges. Bile acids were eluted from the cartridges with methanol after washing with water (6) . Evaporated samples were redissolved in methanol and applied to silica gel TLC plates (K6F; Whatman Chemical Separation Inc., Clifton, NJ) and developed with the solvent system of isooctane/ethylacetate/acetic acid (10:10:2 vol/vol). Lanes corresponding to mono-, di-, and trihydroxy bile acids were scraped and 3H and 14C counts measured. 
Results
3H loss from all three double-labeled bile acids was observed during a single transit through the isolated rat liver perfused in a prograde or retrograde fashion. However, 3H loss from double-labeled cholic acid was much less extensive than from lithocholic and chenodeoxycholic acids (Figs. 1-3 ). The rate of decrease of3H/4'C ratios ofdouble-labeled bile acids appearing in the bile was similar in prograde and retrograde studies. A marked difference in the rate of biliary excretion of radiolabeled bile acids was observed in comparing prograde and retrograde studies. The peak biliary excretion of 14C representing bile acids occurred within the 1st 5 min for three bile acids perfused prograde, whereas biliary excretion of "4C was always delayed in retrograde perfusion. Detailed analysis ofthe excretion patterns after substraction of dead space in the first few minutes indicated that peak excretion occurred almost immediately. The recovery of "'C radioactivity in bile during 60 min perfusion was complete in prograde studies; 101±3% for lithocholic acid, 104±4% for chenodeoxycholic acid (means±SD, n = 3), and 95% for cholic acid (mean of two experiments). However, the recovery of administered 14C in bile was not complete during 60 min retrograde perfusion: 49±15% for lithocholic acid, 94±5% for chenodeoxycholic acid (means±SD), and 66% for cholic acid. Cummulated 3H loss from bile acids appearing in bile during 60 min was higher in retrograde (40.7±9.0%) than prograde (21.4±3.5%) perfusion (P < 0.02) with double-labeled chenodeoxycholic acid (Fig. 2) . This difference was not observed with lithocholic acid probably because of the marked delay in its excretion when administered retrograde. Indomethacin inhibited 'H loss from double-labeled chenodeoxycholic acid excreted into bile both in prograde (Fig. 4) and retrograde ( Most of the 3H lost from 3,6 position of bile acids was recovered in perfusates. During the 1st 5 min after the injection ofdouble-labeled lithocholic and chenodeoxycholic acids, considerable amounts of 3H counts were recovered in perfusates both in prograde and retrograde perfusion (Table I) . In comparing this initial 3H loss into perfusates, significantly greater release from [3,B-3H~lithocholic acid was found in retrograde as compared with prograde studies. A similar trend was seen in studies with radiolabeled chenodeoxycholic acid, but did not reach statistical significance. In the presence of indomethacin, less 3H was released from radiolabeled chenodeoxycholic acid into the perfusates (Table I) . Because of the small sample size, this difference reached significance only in the =) aR retrograde case. After the 1st 5 minutes, the 3H concentration in perfusate samples was too low to allow for the accurate comparison of sinusoidal release with and without indomethacin. Extraction of all three bile acids administered as tracer boluses either prograde or retrograde was complete in the presence or. absence of indomethacin. Release of '4C into perfusates was negligible (< 2% of total activity) during 60 min perfusions (not shown). Neither extraction of the tracer bolus of bile acid nor reflux of bile acid into the perfusate was affected by indomethacin. Table II shows the extent of hydroxylation of double-labeled lithocholic and chenodeoxycholic acids appearing in bile after a single transit through the isolated perfused rat liver. Significantly greater hydroxylation of lithocholic and chenodeoxycholic acids occurred in retrograde than prograde perfusions. Indomethacin had no significant effect on the hydroxylation of chenodeoxycholic acid in prograde or retrograde perfusions (Table II) . Table III shows 3H/'4C ratios of hydroxylated forms ofbile acids in pooled 60 min bile collections. Greater 3H loss was observed in retrograde than prograde perfusions. In the experiments with double-labeled lithocholic acid, little 3H loss ofthe parent lithocholic acid was observed. Esterification of the 3a-OH position of lithocholic acid did not occur extensively (11±3% of lithocholic acid in prograde and 27±5% of lithocholic acid in retrograde perfusions). Thus, the lack of 3H loss could not be accounted for by esterification of the 3a-OH group of lithocholic acid, which would prevent equilibrium cycling by 3a-HSD. Fig. 6 shows the effects ofindomethacin on the continuous prograde infusion ofglycocholic acid in isolated rat liver. With 50 MM glycocholic acid, indomethacin increased bile flow and decreased the concentration of glycocholic acid in bile. However, the biliary excretion rate of glycocholic acid did not change during concomitant infusion with indomethacin. The net steady state extraction of glycocholic acid was reversibly decreased by indomethacin. The inhibition of extraction was not accompanied by a fall in excretion. With 5 ,uM glycocholic acid, indomethacin inhibited both extraction and excretion (Fig. 6) . Excretion appeared to diminish more than extraction. There was no evidence for nonspecific toxicity by indomethacin in these experiments as monitored by 02 consumption, perfusion pressure, or cytosolic enzyme release.
Discussion
In the preceding paper, we have documented the validity of monitoring 3H loss from the 3# position ofbile acids as a probe of their interaction with a cytosolic enzyme, 3a-HSD. This enzyme under physiologic conditions catalyzed bidirectional oxidoreduction of the C3 position on bile acids, without net conversion to 3-oxo bile acids. Our previous studies, which utilized isolated hepatocytes, demonstrated the potential for use of the double-labeled bile acid probes. However, isolated cells in suspensions lose their polarity, and bile acids can cycle back and forth across the plasma membrane. Due to these limitations, we turned to a more physiologic model, the isolated perfused liver. Using this model, the extent of interaction of bile acids with cytosolic 3a-HSD, as assessed by 3H loss, could be determined during a single transit from perfusate to bile. Furthermore, the perfised liver model provides the opportunity to assess the effect of direction of flow or zonation on 3H loss. Others have shown that bile acid excretion during prograde perfusion is much more rapid than in retrograde perfusion, whereas bile acid metabolism (hydroxylation) is much more extensive in the retrograde perfusion (1 1). These observations suggest that zone III hepatocytes retain and more extensively biotransform bile acids as compared with zone I hepatocytes.
Our findings were in general agreement with zonal differences reported by others with respect to the rate of excretion (11, 12) and extent of hydroxylation (1 1). Double-labeled cholic, chenodeoxycholic, or lithocholic acids given as tracer boluses were virtually completely extracted in prograde and retrograde studies. In prograde studies, nearly complete recovery of the bile acids occurred in bile in I h. In the retrograde studies excretion of bile acid was delayed, so that the recovery was incomplete after i h bile collection. Minimal 3H loss from cholic acid was observed during one transit through the liver into bile, which could be anticipated based on the lower affinity of 3a-HSD for cholic acid (5) . In contrast, in the case of lithocholic or chenodeoxycholic acids, extensive 3H loss was observed. Approximately 20% of the 3H was lost with either bile acids given prograde; the bulk of this 3H loss from biliary bile acids occurred in the 1st 15 min after prograde administration and was reflected in the recovery of most of the lost 3H in perfusate samples within the 1st 5 min. With retrograde administration, 3H loss from bile acids excreted in bile was Values are mean percentages±SD of three experiments on three hydroxylated forms of bile acids in the bile. All comparisons of prograde vs. retrograde were significantly different (*P < 0.01, *P < 0.05, unpaired t test). There was no significant difference in percentage of individual hydroxy forms when comparing perfusion without and with indomethacin in the retrograde and prograde studies with chenodeoxycholic acid. more extensive for chenodeoxycholic (-40%) than for lithocholic acid (-20%). With the former, the bulk of3H loss from biliary bile acids occurred in the 1st 25-30 min, but in the case of the latter, 3H loss was continuing to increase over 60 min. Despite the delay in bile acid excretion and greater 3H loss in retrograde studies, two thirds to three fourths of total 3H lost from biliary bile acids in one hour was recovered in the perfusate in the 1st 5 min, during which time no labeled bile acid had been excreted in bile. Thus, it would appear that 3H loss occurs very rapidly in zone III and, therefore, delayed excretion from zone III into bile is not the major cause ofgreater 3H loss from chenodeoxycholic acid. Possible differences in the content of 3a-HSD or in nucleotide cofactor redox state may contribute to greater 3H loss in retrograde studies. Indomethacin has been reported to be a potent inhibitor of 3a-HSD (13, 14) . We previously demonstrated its ability to inhibit 3,8-3H loss from bile acids catalyzed by the pure enzyme and in hepatocyte suspensions. Our studies in cells revealed the very interesting finding that indomethacin caused a shift in the equilibrium distribution ofbile acids (displacement from the cells into the media) without affecting initial rates of uptake. In the present studies, the perfused liver model provided a means to further assess the significance ofinhibition of 3a-HSD by indomethacin in the overall translocation of bile acids from perfusate to bile.
During perfusion with indomethacin there was both a marked inhibition of 3H loss (in bile acid excreted in bile in 1 h) as well as in 3H appearance in effluent perfusate in the 1st 5 min. In parallel with this inhibition of 3a-HSD, there was an inhibition of bile acid excretion into bile in both prograde and retrograde studies. In the prograde studies, peak excretion into bile occurred almost immediately in the absence or presence of indomethacin. The peak height and subsequent rate of excretion were significantly decreased in the presence of indomethacin. In the retrograde studies, peak excretion not only was inhibited but was significantly delayed.
In contrast to our findings in isolated hepatocytes, indomethacin did not displace bile acids from the liver into the perfusate. Rather, it caused increased retention of bile acids in the liver. The different experimental conditions of the two models may explain the apparent discrepancy. In the cell studies, bile acid concentrations accumulating in 2 X 106 cells incubated in 1 ml buffer (5 AM bile acid) could lead to saturation of intracellular sites for bile acids. Therefore, when indomethacin displaced bile acids from 3a-HSD, bile acids were released into the medium possibly because the cells were loaded with bile acids. In the perfused liver studies, only tracer amounts of bile acids were administered to livers largely depleted ofendogenous bile acids. Therefore, indomethacin did not cause the net release of the tracer bile acid, but delayed its excretion. Although inhibition ofexcretion could be due to a direct effect of indomethacin on the excretory step, the data with glycocholate infusions suggests that this is not the case. Therefore, such a delay in excretion implies that displacement of bile acids from 3a-HSD leads to possible redistribution within the cells to a compartment(s) that contributes to the delay in transit through the hepatocyte. This suggests that cytosolic compartmentation of bile acids is involved in the excretion and that redistribution out of the cytosol to undefined sites in the hepatocytes delays excretion. These findings are consistent with the importance of binding to 3a-HSD in retaining bile acids in the cytosolic compartment from which these molecules undergo transport into bile.
Having (Fig. 6 ), indomethacin has a greater effect on extraction or excretion. At the high load, the concentration of glycocholate in the liver exceeds the excretory maximum, and displacement from 3a-HSD by indomethacin leads to regurgitation into the sinusoid and a consequent fall in net extraction. There also may be subcellular redistribution within the liver, but the results indicate that sufficient bile acid is still available to the canalicular transport to maintain the same maximum excretion rate. Thus, the fall in extraction and possible redistribution caused by indomethacin were insufficient to limit the saturating hepatic concentration ofbile acid available for excretion. At infusion rate of 5 ,uM glycocholate, well below Tm., when indomethacin displaces bile acid from 3a-HSD, the displaced bile acid can either regurgitate (fall in net extraction) or undergo subcellular redistribution in the liver. If only regurgitation occurred, the fractional fall in extraction would determine and equal that in excretion. However, the fall in excretion greatly exceeded the fall in extraction. Therefore, the displaced bile acid must also have redistributed in the liver. Extending this interpretation to the tracer bolus perfusion experiments, displacement of the very small bile acid load by indomethacin leads to subcellular redistribution and delayed excretion with no detectable fall in extraction. Thus, displacement of bile acid from 3a-HSD by indomethacin will result under the same perfusion conditions in inhibition of extraction and/or excretion of the bile acid depending on the load. In the isolated hepatocyte studies, the cells become loaded with bile acid so that displacement from the cells would be expected (analogous to decreased net extraction). Thus, the perfused liver studies with different loads of glycocholate provide evidence that explains apparent differences between the indomethacin-induced displacement from isolated cells and delayed tracer bolus excretion from the perfused liver.
Since we have shown in isolated cells that indomethacin does not affect initial uptake rates of bile acids, the fall in extraction of glycocholate is consistent with displacement from intracellular cytosolic sites and efflux (reverse transport). Thus, extraction represents a net result of bidirectional movement across the plasma membrane that may be determined by the free concentration of bile acid outside and inside the cell. Indomethacin may increase reverse transport by displacing bile acids from cytosolic protein, especially 3a-HSD, into the intracellular pool of free bile acid. It is also possible that displacement from GSH S-transferases contributes to the effect, but is less likely due to its much lower affinity for indomethacin as compared with 3a-HSD (Takikawa, H., A. Stolz, and N. Kaplowitz, unpublished observations).
In summary, our work using 3H loss from double-labeled bile acids and inhibition by indomethacin indicates the probable importance of the interaction of bile acids with a specific cytosolic component, 3a-HSD, in the intracellular transit of bile acids from sinusoid to canaliculus.
